New model predicts Barrett’s oesophagus recurrence
Dutch clinicians say their tool can help guide individualised post-treatment surveillance based on patient risk
A new model that predicts visible recurrence after endoscopic eradication of Barrett’s oesophagus with dysplasia or early cancer can help establish a personalised follow-up strategy for patients, researchers say.
The prognostic model, which has been externally validated, was built using data from adults in the Dutch Barrett Expert Center Registry who underwent endoscopic treatment.
